Northeastern University professors of pharmacy say the updated COVID-19 vaccines available for fall and winter of 2024 are a ...

An abundance of evidence indicates the mRNA COVID-19 vaccines are remarkably safe and work well to protect against severe ...

Novavax has inked another settlement for a past COVID-19 vaccine supply deal. | Novavax has inked another settlement for a ...

An Omicron-specific, self-amplifying mRNA booster vaccine for ... The event brings together over 900 attendees from both academic institutions and leading pharma and biotech companies. The 2024 ...

Antiviral Immunoglobulin Market. The global antiviral immunoglobulin market was valued at USD 4.6 billion in 2022 and is ...

Please see the forward-looking statement disclaimer on the company's press release issued earlier today, as well as the risk factors section in our most recent form 10-K and in subsequent ... Meiji ...

The booster shot – called mRNA-1273.211 – offered better and longer-lasting protection compared to the original SpikeVax shot against all SARS-CoV-2 variants, including the prevailing Omicron ...

Request To Download Free Sample of This Strategic Report @- The Global X-ray Photoelectron Spectroscopy (XPS) Market is poised for significant growth, with projections indicating a reach of over USD ...

The facility is the centrepiece of a 10-year agreement-in-principle between ... vaccine candidate against the newer variants like Omicron if authorised, for delivery in 2022 and 2023.

BioNTech invites investors and the general public to join a conference call and webcast with investment analysts today, November 4, 2024, at 8:00 a.m. EST (2:00 p.m. CET) to report its financial ...

Q2 2025 Earnings Conference Call October 31, 2024 2:30 AM ET. Company Participants. Hiroyuki Okuzawa - Representative Director, Presi ...